BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 11287022)

  • 1. Serum human chorionic gonadotropin levels are correlated with body mass index rather than route of administration in women undergoing in vitro fertilization--embryo transfer using human menopausal gonadotropin and intracytoplasmic sperm injection.
    Elkind-Hirsch KE; Bello S; Esparcia L; Phillips K; Sheiko A; McNichol M
    Fertil Steril; 2001 Apr; 75(4):700-4. PubMed ID: 11287022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human menopausal gonadotropin versus recombinant follicle-stimulating hormone in normogonadotropic women down-regulated with a gonadotropin-releasing hormone agonist who were undergoing in vitro fertilization and intracytoplasmic sperm injection: a prospective randomized study.
    Westergaard LG; Erb K; Laursen SB; Rex S; Rasmussen PE
    Fertil Steril; 2001 Sep; 76(3):543-9. PubMed ID: 11532479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrauterine administration of hCG immediately after oocyte retrieval and the outcome of ICSI: a randomized controlled trial.
    Navali N; Gassemzadeh A; Farzadi L; Abdollahi S; Nouri M; Hamdi K; Mallah F; Jalilvand F
    Hum Reprod; 2016 Nov; 31(11):2520-2526. PubMed ID: 27680029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delaying human chorionic gonadotropin administration in human menopausal gonadotropin-induced cycles decreases successful in vitro fertilization of human oocytes.
    Laufer N; DeCherney AH; Tarlatzis BC; Zuckerman AL; Polan ML; Dlugi AM; Graebe R; Barnea ER; Naftolin F
    Fertil Steril; 1984 Aug; 42(2):198-203. PubMed ID: 6430722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrauterine injection of human chorionic gonadotropin before embryo transfer significantly improves the implantation and pregnancy rates in in vitro fertilization/intracytoplasmic sperm injection: a prospective randomized study.
    Mansour R; Tawab N; Kamal O; El-Faissal Y; Serour A; Aboulghar M; Serour G
    Fertil Steril; 2011 Dec; 96(6):1370-1374.e1. PubMed ID: 22047664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of low-dose human chorionic gonadotropin combined with human menopausal gonadotropin protocol on women with hypogonadotropic hypogonadism undergoing ovarian stimulation for in vitro fertilization.
    Jiang S; Kuang Y
    Clin Endocrinol (Oxf); 2018 Jan; 88(1):77-87. PubMed ID: 28960429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triggering final oocyte maturation with reduced doses of hCG in IVF/ICSI: a prospective, randomized and controlled study.
    Lin H; Wang W; Li Y; Chen X; Yang D; Zhang Q
    Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):143-7. PubMed ID: 21824709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of exogenous gonadotropin and ovarian response in in vitro fertilization.
    Nagata Y; Honjou K; Sonoda M; Sumii Y; Inoue Y; Kawarabayashi T
    Fertil Steril; 1999 Aug; 72(2):235-9. PubMed ID: 10438987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human chorionic gonadotropin (rhCG) in assisted reproductive technology: results of a clinical trial comparing two doses of rhCG (Ovidrel) to urinary hCG (Profasi) for induction of final follicular maturation in in vitro fertilization-embryo transfer.
    Chang P; Kenley S; Burns T; Denton G; Currie K; DeVane G; O'Dea L
    Fertil Steril; 2001 Jul; 76(1):67-74. PubMed ID: 11438321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Periovulatory serum human chorionic gonadotropin (hCG) concentrations following subcutaneous and intramuscular nonrecombinant hCG use during ovulation induction: a prospective, randomized trial.
    Sills ES; Drews CD; Perloe M; Kaplan CR; Tucker MJ
    Fertil Steril; 2001 Aug; 76(2):397-9. PubMed ID: 11476796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual trigger for final oocyte maturation improves the oocyte retrieval rate of suboptimal responders to gonadotropin-releasing hormone agonist.
    Lu X; Hong Q; Sun L; Chen Q; Fu Y; Ai A; Lyu Q; Kuang Y
    Fertil Steril; 2016 Nov; 106(6):1356-1362. PubMed ID: 27490046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duphaston and human menopausal gonadotropin protocol in normally ovulatory women undergoing controlled ovarian hyperstimulation during in vitro fertilization/intracytoplasmic sperm injection treatments in combination with embryo cryopreservation.
    Zhu X; Ye H; Fu Y
    Fertil Steril; 2017 Sep; 108(3):505-512.e2. PubMed ID: 28697910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progesterone/estradiol ratio <0.25 on the day of human chorionic gonadotropin administration is associated with adverse pregnancy outcomes in prolonged protocols for in vitro fertilization/intracytoplasmic sperm injection.
    Li Y; Luo K; Tang Y; Lin G; Lu G; Gong F
    Taiwan J Obstet Gynecol; 2017 Feb; 56(1):27-31. PubMed ID: 28254221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of highly purified human menopausal gonadotropin vs. recombinant follicle-stimulating hormone in first-cycle in vitro fertilization-intracytoplasmic sperm injection patients.
    Hompes PG; Broekmans FJ; Hoozemans DA; Schats R;
    Fertil Steril; 2008 Jun; 89(6):1685-93. PubMed ID: 17681325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flexibility in starting ovarian stimulation at different phases of the menstrual cycle for treatment of infertile women with the use of in vitro fertilization or intracytoplasmic sperm injection.
    Qin N; Chen Q; Hong Q; Cai R; Gao H; Wang Y; Sun L; Zhang S; Guo H; Fu Y; Ai A; Tian H; Lyu Q; Daya S; Kuang Y
    Fertil Steril; 2016 Aug; 106(2):334-341.e1. PubMed ID: 27114329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective randomized comparison of routine buserelin acetate and a decreasing dosage of nafarelin acetate with a low-dose gonadotropin-releasing hormone agonist protocol for in vitro fertilization and intracytoplasmic sperm injection.
    Takeuchi S; Minoura H; Shibahara T; Tsuiki Y; Noritaka F; Toyoda N
    Fertil Steril; 2001 Sep; 76(3):532-7. PubMed ID: 11532477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles.
    Lin MH; Wu FS; Lee RK; Li SH; Lin SY; Hwu YM
    Fertil Steril; 2013 Nov; 100(5):1296-302. PubMed ID: 23993928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural-cycle in vitro fertilization combined with in vitro maturation of immature oocytes is a potential approach in infertility treatment.
    Chian RC; Buckett WM; Abdul Jalil AK; Son WY; Sylvestre C; Rao D; Tan SL
    Fertil Steril; 2004 Dec; 82(6):1675-8. PubMed ID: 15589878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Falling estradiol levels on day after human chorionic gonadotropin administration in assisted reproductive technology cycles are not predictive of decreasing oocyte maturity or pregnancy rates.
    Levy G; Hill M; Beall S; Pilgrim JD; Payson M; Propst A
    J Reprod Med; 2014; 59(5-6):255-9. PubMed ID: 24937966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can in vitro fertilization cycles be salvaged by repeat administration of intramuscular human chorionic gonadotropin the day after failed injection?
    Reichman DE; Greenwood E; Meyer L; Kligman I; Rosenwaks Z
    Fertil Steril; 2012 Sep; 98(3):671-4. PubMed ID: 22769734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.